- In a first, SpaceX 'catches' megarocket booster after test flight
- Bangladeshi Hindus shrug off attack worries to celebrate festival
- Ubisoft fears assassin's hit over falling sales
- Vietnam, China hold talks on calming South China Sea tensions
- SpaceX will try to 'catch' giant Starship rocket shortly before landing
- Japan's former empress Michiko discharged after surgery: reports
- Japan's former empress Michiko discharged after surgey: reports
- 'Little Gregory' murder haunts France 40 years on
- Tariffs, tax cuts, energy: What is in Trump's economic plan?
- Amazon wants to be everything to everyone
- Jewish school in Canada hit by gunfire for second time
- With medical report Harris seeks to play health card against Trump
- China-EU EV tariff talks in Brussels end with 'major differences': Beijing
- Buried Nazi past haunts Athens on liberation anniversary
- Harris to release medical report confirming fitness for presidency: campaign
- Nobel prize a timely reminder, Hiroshima locals say
- China offers $325 bn in fiscal stimulus for ailing economy
- Small Quebec company dominates one part of NHL hockey: jerseys
- Boeing to cut 10% of workforce as it sees big Q3 loss
- Want to film in Paris? No sexism allowed
- US, European markets rise as investors weigh rates, earnings
- In Colombia, children trade plastic waste for school supplies
- JPMorgan Chase profits top estimates, bank sees 'resilient' US economy
- Little progress at key meet ahead of COP29 climate summit
- 'Party atmosphere': Skygazers treated to another aurora show
- Kyrgyzstan opens rare probe into glacier destruction
- European Mediterranean states discuss Middle East, migration
- Thunberg leads pro-Palestinian, climate protest in Milan
- Stock markets diverge before China weekend briefing
- EU questions shopping app Temu over illegal products risk
- Han Kang's books sell out in South Korea after Nobel win
- Shanghai markets sink ahead of briefing on mixed day for Asia
- Investors, analysts eye bigger China stimulus at Saturday briefing
- Musk unveils robotaxi, pledges it 'before 2027'
- At least 11 dead in Florida but Hurricane Milton not as bad as feared
- Asian markets mixed after Wall St drop, Shanghai dips before briefing
- Automaker Stellantis says CEO will retire in 2026
- Musk's promised robotaxi unveil delayed
- On US coast, wind power foes embrace 'Save the Whales' argument
- At least 10 dead in Florida after Hurricane Milton spawns tornadoes
- Internet Archive reels from 'catastrophic' cyberattack, data breach
- Wall Street stocks retreat from records on US inflation data
- Israel strikes central Beirut, killing 22
- Solar storm could impact US hurricane recovery efforts: agency
- Delta eyes Election Day travel pullback as profits climb
- Florida battered by hurricane, floods but spared 'worst-case scenario'
- UK's William and Kate in first joint public engagement since cancer treatment
- Over 200 women in legal talks with Harrods over Fayed abuse claims
- A very stiff breeze: BBC says sorry for 20,000 kph wind forecast
- Musk finally unveiling his long-promised robotaxi
Discovering HIV started 'race against time': Barre-Sinoussi
When Nobel laureate Francoise Barre-Sinoussi helped identify a mysterious virus that would become known as HIV 40 years ago, she says it kicked off a "race against time" to counter the looming AIDS crisis.
In an interview with AFP, the 75-year-old virologist described how she and colleagues at the Pasteur Institute in Paris discovered HIV in 1983, which led to her jointly winning the Nobel Prize for Medicine.
"It all started in 1982," when doctors started sharing stories about the first French AIDS patients, France's Barre-Sinoussi said.
"They were convinced that a retrovirus could be responsible for this new disease."
For more than a decade Barre-Sinoussi had been working on retroviruses, which on infection convert from the genetic material RNA into DNA, allowing them to easily integrate host cells.
In January 1983, the team's strategy was to take a lymph node biopsy from a sick patient, then culture the cells in the lab looking for "very specific enzymatic activity", she said.
Her French doctor colleagues thought that AIDS must be caused by HTLV-1, the only retrovirus known to directly cause cancer in humans.
"But our team did not believe in this hypothesis because this virus causes a proliferation of lymphocytes," Barre-Sinoussi said.
AIDS patients had lower rates of this important immune cell.
"Something didn't add up," she said.
"In May 1983, we isolated the virus and demonstrated that it was a retrovirus that was different from HTLV-1. But we were not yet certain that it caused AIDS."
That was confirmed the following year by US scientist Robert Gallo.
This caused a transatlantic rift over who discovered HIV, with the United States and France eventually agreeing that both Gallo and the Pasteur team led by Luc Montagnier should get joint credit.
- 'Enormous' challenge ahead -
Finally, researchers around the world had a target to aim for in their efforts to combat AIDS, which was rapidly spreading and devastating communities.
"From then on, the task was enormous because we were faced with an unknown virus," Barre-Sinoussi said.
"We had to learn everything about it, find out what proteins it contained, its genetic material, what type of cells it infected, the consequences of this infection."
A crucial first step was to develop tests as quickly as possible, both to diagnose patients and to demonstrate that HIV only infected AIDS patients.
"Only then could strategies be considered to try to block it," she said.
"It was a race against time because we realised that the virus was transmitted by blood, sex and from mother to child."
The endeavour required the swift mobilisation of immunologists, molecular biologists and doctors, she said.
Not to mention patients, even though scientists knew "we would not have time to find a treatment that could save them", she said.
"We found ourselves faced with people who came to the Pasteur Institute to ask us questions about the virus," she said.
"It was very difficult."
- Nobel 'recognised a community' -
In 2008, Barre-Sinoussi and her former mentor, Luc Montagnier, jointly received the Nobel medicine prize for the discovery of HIV.
"I was in Cambodia when I heard the news. It was a huge surprise. I did not expect it all," Barre-Sinoussi said.
"People living with HIV in the country came up to me with smiles and bouquets of flowers.
"I understood that this prize recognised a community that had been working together from the beginning."
"All levels of society have been affected by HIV/AIDS, which has always been a battle on multiple fronts -- scientific of course, but also political, societal (and) against pharmaceutical companies," she said.
When she started her career, "I was a researcher who never left the laboratory", she said.
But after helping discover HIV, things changed. "I suddenly found myself faced with things that I never imagined possible, such as the general public's lack of tolerance towards certain people," she said.
"Patients were stigmatised, abandoned by their families, their friends, sometimes by health professionals. Some lost their homes, their jobs."
Barre-Sinoussi said that she had also "learned a lot about inequalities, which unfortunately may have become even worse today".
Throughout her long career, Barre-Sinoussi worked continuously towards finding a cure for HIV, serving as the president of the International AIDS Society a decade ago. She retired in 2017.
Y.Jeong--CPN